About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Miami | 12,544 Studies Near You

Clinical TrialsMiami

Clinical Trials in Miami

Discover 12,544 clinical trials near Miami, Florida. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 601-620 of 12,544 trials

CompletedA Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)The purpose of this study was to demonstrate similarity of NI-071 (proposed biosimilar to infliximab) to US REMICADE® (reference product) in terms of safety and efficacy in…NCT02990806·Little Rock, Arkansas and 133 others

Find Trials by Condition in Miami

Breast Cancerin Miami Lung Cancerin Miami Prostate Cancerin Miami Colorectal Cancerin Miami Melanomain Miami Leukemiain Miami Lymphomain Miami Pancreatic Cancerin Miami Ovarian Cancerin Miami Brain Cancerin Miami Diabetesin Miami

Data from ClinicalTrials.govTerms

Active not recruitingAn International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care (SOC), versus Standard of Care alone, in adult male…NCT04720157·Scottsdale, Arizona and 166 others

CompletedVeterans Individual Placement and Support Towards Advancing RecoveryThe primary objective of CSP#589 VIP-STAR is to evaluate the effectiveness of Individual Placement \& Support (IPS) in unemployed Veterans with PTSD.NCT01817712·Birmingham, Alabama and 12 others

Active not recruitingA Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk MelanomaThis phase II trial studies how pembrolizumab works before and after surgery in treating patients with stage III-IV high-risk melanoma.NCT03698019·Birmingham, Alabama and 814 others

Active not recruitingTesting the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment TrialThis phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal)…NCT05554328·Birmingham, Alabama and 294 others

CompletedEffects of Changing HIV Therapy at Lower Versus Higher Viral LoadsThis study will look at people who have been taking anti-HIV drugs but still have detectable levels of HIV.NCT00036465·Menlo Park, California and 22 others

CompletedQuetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I ManiaThe purpose of this study is to demonstrate efficacy and safety of quetiapine fumarate (SEROQUEL) compared with placebo in the treatment of children and adolescent patients with…NCT00090311·Scottsdale, Arizona and 31 others

CompletedEfficacy and Safety of Trichuris Suis Ova (TSO) as Compared to PlaceboThis is a randomized, double-blind, placebo-controlled, multicenter, and proof of concept study with a parallel group design to evaluate the safety and efficacy of oral Trichuris…NCT01576471·Tucson, Arizona and 72 others

RecruitingA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisThis is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to…NCT07185009·Tucson, Arizona and 54 others

No longer availableExpanded Access Program for CT1812 (Zervimesine)This is a multi-center, open label, expanded access program (EAP) that will provide 100 mg CT1812 for up to one year to participants with mild-to-moderate DLB.NCT06961760·Sun City, Arizona and 7 others

Active not recruitingA Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous UrticariaThe purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately…NCT06445023·Birmingham, Alabama and 234 others

CompletedA Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3To evaluate the safety, tolerance, pharmacokinetics, and efficacy of delavirdine mesylate (U-90152S) in combination with didanosine (ddI) versus ddI alone in HIV-positive patients.NCT00002123·Birmingham, Alabama and 83 others

CompletedSafety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With BlepharitisThe purpose of this study is to evaluate the safety and efficacy of AzaSite® ophthalmic solution, 1% on signs and symptoms of blepharitis.NCT00629980·Artesia, California and 8 others

CompletedEffect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female SubjectsRandomized, open-label, 2-period, 2-sequence, crossover study to evaluate the effect of a standard meal on the pharmacokinetic (PK) profile of orally administered RP-G28.NCT03563846·Miami, Florida

WithdrawnDiabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)The study is a prospective, randomized, double-blind, placebo-controlled, multi-center trial in subjects with new onset T1D.NCT03794973·Miami, Florida

CompletedA Study of IDN-6556 in Cirrhotic Subjects With Portal HypertensionThis is an open-label pilot study to evaluate the safety, tolerability, and efficacy of IDN-6556 in treating portal hypertension in subjects with liver cirrhosis.NCT02230683·West Haven, Connecticut and 15 others

CompletedSafety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.The objective of this trial is to evaluate the safety and efficacy of Xyrem® in long term use.NCT00423605·Anniston, Alabama and 90 others

CompletedStudy of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART RegimensThe primary purpose of the study is to assess the safety and pharmacokinetics of KP-1461 given every 12 hours for 14 days when administered to HIV+ patients who have failed…NCT00129194·Bradenton, Florida and 8 others

TerminatedTargeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung CancerThis National Cancer Institute (NCI)-NRG ALK Protocol phase II trial studies how well a combination of different biomarker/ALK inhibitors work in treating patients with stage IV…NCT03737994·Goodyear, Arizona and 490 others

Active not recruitingA Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE)…NCT05617677·Birmingham, Alabama and 196 others

PreviousPage 31 of 628Next

Heart Diseasein Miami